# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their ...
TB206-001 shown to be a high-affinity, cross-reactive humanized antibody antagonist of A2AR with in vivo tumor suppressing acti...
Guggenheim analyst Subbu Nambi initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Buy rating and announces Price Ta...
No limit to number of fragments included in the poolsOptimized chemistry enables direct synthesis of up to 500 bp double strand...
On Wednesday, Cathie Wood’s Ark Invest made some significant trades.